Science Summit at United Nations General Assembly (UNGA78)

Plant molecular farming has emerged as an alternative biomanufacturing process for the production of biopharmaceuticals especially in developing countries. This platform for biopharmaceutical production has been validated by products manufactured and supplied by many companies in the industry viz. Plantform, Leaf expression systems and Cape Bio Pharms. This track record demonstrates its potential for socioeconomic change, commercial viability and feasibility as well as prospects for the introduction of circularity into the production process. Adoption of the plant platform technology has occurred at a steady pace with some molecules for Covid-19 recently being licensed, and others advancing towards phase 1 clinical trials. With more than 30 years of intensive research and development activities now having been invested in the field, great strides within the technical and regulatory landscape have now been made. It appears the field has reached a major tipping point towards wider acceptance and greater adoption. This session brings together leaders and experts within the field of plant-made pharmaceuticals to share advances within the field, their key insights and enlighten us on the future prospects of Plant Molecular Farming.


https://us02web.zoom.us/rec/share/pY3xw6wUdd72MwJYUb_2FQEpef1Q6MUCKxWhW7QacbEkZgp-FoquStGLRW9ShlfB.dK0Q-fIehZB6uZsJ